Prosiectau fel Prif Ymchwiliwr
- AML 16 GZ evaluation (01.11.2011 - 30.03.2013)
- AML 18 trial (01.02.2013 - 31.01.2014)
- A phase II/III trial for older patients with acute myeloid leukaemia and high risk myelodysplastc syndrome: Intensive Arm - AML 16 (01.08.2006 - 30.06.2013)
- A programme of development for older patients with acute myeloid leukaemia and high risk myelodyspastic syndrome (01.03.2012 - 31.08.2013)
- IL-1 (20.05.2015 - 31.08.2015)